{"id":"W2152798629","doi":"10.1056/nejmoa0801317","title":"Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3513,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"Canadian Institutes of Health Research; Servier; Heart and Stroke Foundation of Canada; Novo Nordisk; Sanofi; AstraZeneca; Bristol-Myers Squibb","keywords":"Ramipril; Telmisartan; Medicine; Diabetes mellitus; ACE inhibitor; Angiotensin Receptor Blockers; Internal medicine; Heart failure; Cardiology; Angiotensin-converting enzyme; Vascular disease; Pharmacology; Endocrinology; Blood pressure","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}